News & Events
-
June 1, 2015
Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarker
TUCSON, Ariz., June 1, 2015 — The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has issued a Letter of Support to C-Path’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) for the use of total kidney volume (TKV) as a prognostic biomarker to select patients for clinical trials of new therapies for Autosomal Dominant Polycystic Kidney Disease (ADPKD).
ADPKD is a debilitating genetic disease affecting more than 600,000 Americans and 12 million people worldwide. It is characterized by progressive enlargement of the kidneys due to the formation and growth of cysts. TKV is a measurement of the impact of ADPKD on the size of the kidneys and is believed to be predictive of a future decline in kidney function -
May 19, 2015
Critical Path Institute Launches New Neonatal Consortium
May 19, 2015 Critical Path Institute Launches New Neonatal Consortium The International Neonatal Consortium (INC) aims to accelerate the development of safe, effective therapies for newborns. TUCSON, Ariz., May 19, 2015 — Today, the Critical Path Institute (C-Path), a pioneering non-profit organization dedicated to accelerating the pace and reducing the costs of medical product development... -
May 6, 2015
Migrating a PRO Instrument
This webinar provides a detailed description of the process for conducting paper to ePRO migration, mode-specific migrations, usability, feasibility and user acceptance testing as well as case studies of successful migrations. Presenters: Serge Bodart, MSc (Biomedical Systems) Alisandra Johnson, BS (Bracket) PDF version -
May 4, 2015
C-Path Selected as Host For New TB Clinical Trial Data-Sharing Platform
May 4, 2015 Host For New TB Clinical Trial Data-Sharing Platform Selected TUCSON, Ariz., May 4, 2015 — The non-profit Critical Path Institute has been selected to host a new tuberculosis (TB) clinical trial data sharing platform. The initiative will start by creating a common database from three Phase III clinical trials earlier supported by... -
April 29, 2015 - April 30, 2015
Sixth Annual Patient-Reported Outcome Consortium Workshop
Partners in Progress: Sharing the Vision, Shaping the Future April 29 – 30, 2015 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 The Patient-Reported Outcome (PRO) Consortium is a public-private partnership established by the Critical Path Institute (C-Path) in cooperation with the U.S. Food and Drug Administration (FDA) and the medical...